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Purpose. Gastrointestinal tract is one of the rare locations for breast cancer metastasis. This paper shows such metastasis may occur
even in the absence of breast metastasis in other more common locations. Case Report. A 64-year old female was admitted to the
hospital with abdominal discomfort and diarrhea. She had breast carcinoma treated 7 years previously with normal follow-up
since. Colonoscopy showed hepatic ﬂexure thickening that was conﬁrmed to be breast metastasis. Staging investigations showed
upper and lower gastrointestinal tract metastasis with negative ﬁndings elsewhere. Conclusion. Although more common causes for
gastrointestinal symptoms should be excluded, however, a high index of suspicion of metastatic breast cancer is needed when such
patients develop gastrointestinal symptoms.
1.Introduction
Breastcarcinomaisthemostcommonmalignancyinwomen
and is a leading cause for cancer-related mortality [1].
Invasive ductal carcinoma is the most common histological
subtype (70%–80%), followed by invasive lobular carcinoma
(10%–14%) [1, 2]. Approximately 50% of the patients
with breast cancer will develop distant metastases during
their lifetime. However, autopsy data reports even a higher
incidence of subclinical distant metastases [3, 4]. The most
common metastatic sites are lymph nodes, bones, lungs, and
the liver [1].
Gastrointestinal (GI) tract is rarely reported to be
involved by breast cancer metastasis. Nevertheless, breast
cancer comes only second to melanoma in the rate of
metastatic spread to the GI tract [5] .T h et r u er a t eo ft h i s
metastasis is believed to be underestimated as patients may
be asymptomatic or present with nonspeciﬁc symptoms of
nausea, vomiting, or diarrhea that can be easily missed or
attributed to other etiologies like chemotherapy side eﬀects.
Metastasis to the colon is less commonly reported compared
to gastric metastasis [6].
Thiscasereporthighlightstheimportanceofconsidering
GI metastasis as part of the diﬀerential diagnosis when breast
cancer patients present with persistent GI symptoms even in
the absence of metastasis elsewhere.
2.CaseReport
A 64-year old female was admitted to the hospital with
symptoms of abdominal discomfort, diarrhea, and weight
loss. The patient also had intermittent nausea and vomiting
for few months treated as gastritis. Her past medical history
included breast carcinoma which was diagnosed seven
years earlier on screening mammography and was treated
with lumpectomy and axillary node clearance followed by
adjuvant radiotherapy and hormonal treatment (Tamoxifen)
forﬁveyears.Thiswasa32mmgradeoneinﬁltratinglobular
carcinoma (T2 N0 M0) and hormone receptor (Estrogen
(ER) positive, progesterone (PR) negative). Patient remained
well with no clinical or radiological evidence of recurrence
on her regular oncology follow-up visits. Patient was not on
any current medications at this time of admission. She is
nonsmoker. No family history of breast or gastrointestinal
carcinomas.
Physical examination was remarkable for pale sclera,
mild lower abdominal tenderness with no rebound tender-
nessandbowelsoundswerepresent.Rectalexamwasnormal
but fecal occult blood was positive.
Investigations showed normocytic normochromic ane-
mia (Hemoglobin 9.4 grams per deciliter, Mean corpuscular
volume 88.0 femtoliters, and Mean cell hemoglobin 292 Case Reports in Medicine
Figure 1: Large nodular hepatic ﬂexure lesions as seen on Colonoscopy.
(a) (b)
Figure 2: (a) Histopathology of biopsies taken from gastric lesions showing inﬁltrating adenocarcinoma with signet ring cell morphology
(Arrow). (b) Immunohistochemistry of (a) showing positive ER.
picograms).Whitebloodcellcountwas11,000×109/l.Upper
and lower endoscopy were performed which revealed multi-
ple areas of nodular thickening involving the gastric antrum
proximal duodenum and the hepatic ﬂexure of the colon
(Figure 1). Biopsies showed inﬁltrating adenocarcinoma
with signet ring cell morphology suspicious for primary
gastric tumor (Figure 2(a)). However, Immunoperoxidase
stain of the specimen revealed cytokeratin (CK) 7 and ER
both were positive (Figure 2(b)) while CK-20 and CDX2
were negative suggestive of metastatic breast carcinoma.
PR and HER2 were negative. Staging investigations showed
extensive metastasis to the upper and lower GI tract. No
pulmonary or hepatic lesions were identiﬁed and nuclear
bone scan was normal.
The patient was managed initially with palliative hor-
monal treatment (Letrozole) which was changed to palliative
chemotherapy due to disease progression. However, patient
did not tolerate the side eﬀects of chemotherapy and it was
stopped. After seven months of her diagnosis with the breast
cancer metastasis to the GI tract; the patient level of care was
changed to comfort care and symptomatic treatment only
and was transferred to inpatient hospice.
3. Discussion
The reported patient had extensive breast cancer metastasis
to the upper and lower GI tract in the absence of any evident
metastasis else where. Most patients in previous reports had
the GI metastasis as part of a widely metastatic disease
involving the commonly involved organs like the liver, lungs,
or bones [7–9]. These ﬁndings advocate for keeping a high
index of suspicion and a low threshold to further investigate
persistent GI symptoms in patients with breast cancer even
those with clinically early stage with no evident metastasis.
Upper GI tract specially the stomach has been more
commonly reported to be involved with breast cancer
metastasis than the colon and the lower GI tract [6–9].
An autopsy study of 707 breast cancer cases estimated the
metastasis rate to the upper GI tract to be 6%–18% while
the lower GI tract was involved in 8%–12% of the cases [6].
These autopsy results suggest that a signiﬁcant number of
breast cancer patients may have metastasis to the GI tract
that are clinically underdiagnosed due to either being totally
asymptomatic or causing nonspeciﬁc symptoms that could
easily be missed. Indeed the patient in this report had nauseaCase Reports in Medicine 3
and vomiting prior to presentation which were considered
secondary to gastritis.
Histological variants of breast cancer have been shown
to have diﬀerent patterns of metastasis. Inﬁltrating lobular
carcinoma was found to be responsible for the majority of
metastasis to the GI tract [1, 9]. Nonetheless, some reports
described GI metastasis of inﬁltrating ductal carcinoma
[5] .T h es p r e a dt ot h eG It r a c ti sb e l i e v e dt ob eb l o o d
borne in origin [10]. Diﬀerentiation of breast metastasis
from other GI primaries can be diﬃcult to establish using
the histopathological appearance as in the reported case.
Immunohistochemistry is crucial to establish the accurate
diagnosis. Commonly used markers include ER and PR
receptors, CK 7, CK 20, and gross cystic disease ﬂuid protein
15 (GCDFP-15) [11, 12].
Management of breast cancer metastasis to the GI tract
commonly involves systemic hormonal or chemotherapy
treatment.Thesurgicalroleisusuallypalliativeandismainly
indicated in cases of symptomatic stenosis or complete
obstruction. The reported overall response rate to the
diﬀerent treatment modalities is 53% [13].
This report highlights the need for a high index of suspi-
cion for breast cancer metastasis when such patients present
with persistent GI symptoms that failed medical treatment.
Although more common causes should be excluded, metas-
tasis to the GI tract should be included in the diﬀerential
diagnosis which may result in a signiﬁcant alteration in the
management and the outcome of these patients.
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